Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ribosome rescue factor PELOTA modulates translation start site choice and protein isoform levels of transcription factor C/EBPα. | bioRxiv | 2023 | 36711859 | PubTator, text mining | PubMed |
| EGOC inhibits TOROID polymerization by structurally activating TORC1. | Nat Struct Mol Biol | 2023 | 36702972 | PubTator, text mining | PubMed |
| The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the 682YENPTY687 motif. | Comput Struct Biotechnol J | 2023 | 36698966 | PubTator, text mining | PubMed |
| Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond. | Hemasphere | 2023 | 36698615 | PubTator, text mining | PubMed |
| Structure of the lysosomal mTORC1-TFEB-Rag-Ragulator megacomplex. | Nature | 2023 | 36697823 | PubTator, text mining | PubMed |
| Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus. | Mol Biol Rep | 2023 | 36696023 | PubTator, text mining | PubMed |
| Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications. | Molecules | 2023 | 36677746 | PubTator, text mining | PubMed |
| The Neuroprotective Effects and Therapeutic Potential of the Chalcone Cardamonin for Alzheimer's Disease. | Brain Sci | 2023 | 36672126 | PubTator, text mining | PubMed |
| Lessons learned: from mentored to mentor. | J Clin Invest | 2023 | 36647823 | PubTator, text mining | PubMed |
| Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond. | PLoS Pathog | 2023 | 36634035 | PubTator, text mining | PubMed |
| Human DNA-dependent protein kinase activation mechanism. | Nat Struct Mol Biol | 2023 | 36604499 | PubTator, text mining | PubMed |
| Targeted protein degradation as an antiviral approach. | Antiviral Res | 2023 | 36567024 | PubTator, text mining | PubMed |
| Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors. | J Med Chem | 2023 | 36533617 | PubTator, text mining | PubMed |
| Phosphorylation of the novel mTOR substrate Unkempt regulates cellular morphogenesis. | J Biol Chem | 2023 | 36509146 | PubTator, text mining | PubMed |
| A general method for chemogenetic control of peptide function. | Nat Methods | 2023 | 36481965 | PubTator, text mining | PubMed |
| Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia. | Cancer Discov | 2023 | 36455613 | PubTator, text mining | PubMed |
| Mutant NPM1 Hijacks Transcriptional Hubs to Maintain Pathogenic Gene Programs in Acute Myeloid Leukemia. | Cancer Discov | 2023 | 36455589 | PubTator, text mining | PubMed |
| Substrate-selective small-molecule modulators of enzymes: Mechanisms and opportunities. | Curr Opin Chem Biol | 2023 | 36455490 | PubTator, text mining | PubMed |
| Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours. | Nat Rev Clin Oncol | 2023 | 36418477 | PubTator, text mining | PubMed |
| The emerging importance of immunophilins in fibrosis development. | Mol Cell Biochem | 2023 | 36302992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=14